Question:
What types of improper laboratory claims are targeted in potential future OIG and Medicare audits?
Answer:
OIG and Medicare audits will focus on the improper use of claim line modifiers for a code pair, genetic testing, and urine drug testing services. Findings from the audits are expected to identify laboratories or other institutions that routinely submit improper claims, including providers that regularly bill Medicare for definitive drug testing at the highest level (G0483).